Hanyu Pharmaceutical signed a strategic cooperation intention letter with the digital asset platform KuCoin, and the stock price surged to the daily limit

ChainCatcher news, Hanyu Pharmaceutical (300199.SZ) surged in the afternoon to reach the daily limit, quoted at 24.32 yuan, marking a new high since December 2022.

On the news front, Hanyu Pharmaceutical has officially signed a strategic cooperation intention letter with the digital asset platform KuCoin. The two parties plan to jointly explore the first RWA (Real World Asset) tokenization pilot project in mainland China, based on "future revenue rights of innovative drug research and development" as the underlying asset.

According to the agreement, Hanyu Pharmaceutical will use its technological accumulation and research and development pipeline in the GLP-1 peptide blockbuster drug field as the underlying asset, while KuCoin will leverage its advantages in blockchain technology, RWA full-process solutions, and global compliance resources to provide integrated support for the project, including on-chain mapping, asset tokenization, transaction matching, and revenue distribution. (Gelonghui)